IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION
Condition(s):Myocarditis; Heart Failure; Myocardial Fibrosis; Vascular InflammationLast Updated:December 14, 2022Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Myocarditis; Heart Failure; Myocardial Fibrosis; Vascular InflammationLast Updated:December 14, 2022Active, not recruiting
Condition(s):NAFLD/MAFLD; Liver Fibrosis; CMRLast Updated:February 14, 2022Unknown status
Condition(s):Liver Fibrosis; CirrhosisLast Updated:March 15, 2024Enrolling by invitation
Condition(s):Myocardial FibrosisLast Updated:November 14, 2022Completed
Condition(s):Heart Failure With Normal Ejection FractionLast Updated:May 10, 2021Completed
Condition(s):Hypertrophic CardiomyopathyLast Updated:September 3, 2015Unknown status
Condition(s):Aortic RegurgitationLast Updated:April 18, 2022Completed
Condition(s):Congenital Heart Disease; Congenital Heart Defect; Fallot TetralogyLast Updated:December 7, 2021Unknown status
Condition(s):Athlete’s HeartLast Updated:July 21, 2021Completed
Condition(s):Suspected Acute MyocarditisLast Updated:December 11, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.